These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38160285)

  • 41. Drug repositioning based on multi-view learning with matrix completion.
    Yan Y; Yang M; Zhao H; Duan G; Peng X; Wang J
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35289352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing.
    Zhang F; Hu W; Liu Y
    BMC Bioinformatics; 2022 Sep; 23(1):372. PubMed ID: 36100897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and application of a knowledge network for automatic prioritization of drug mechanisms.
    Mayers M; Tu R; Steinecke D; Li TS; Queralt-Rosinach N; Su AI
    Bioinformatics; 2022 May; 38(10):2880-2891. PubMed ID: 35561182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding.
    Islam MK; Amaya-Ramirez D; Maigret B; Devignes MD; Aridhi S; Smaïl-Tabbone M
    Sci Rep; 2023 Mar; 13(1):3643. PubMed ID: 36871056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration.
    Wu G; Liu J; Wang C
    BMC Med Genomics; 2017 Dec; 10(Suppl 5):79. PubMed ID: 29297383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Network controllability solutions for computational drug repurposing using genetic algorithms.
    Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
    Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding.
    Zhu C; Xia X; Li N; Zhong F; Yang Z; Liu L
    Comput Biol Med; 2023 Sep; 164():107262. PubMed ID: 37481946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-cell-led drug repurposing for Alzheimer's disease.
    Parolo S; Mariotti F; Bora P; Carboni L; Domenici E
    Sci Rep; 2023 Jan; 13(1):222. PubMed ID: 36604493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Considerations and challenges for sex-aware drug repurposing.
    Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
    Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Machine-Learning-Based Drug Repurposing Approach Using Baseline Regularization.
    Kuang Z; Bao Y; Thomson J; Caldwell M; Peissig P; Stewart R; Willett R; Page D
    Methods Mol Biol; 2019; 1903():255-267. PubMed ID: 30547447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
    Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
    BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug Repurposing for Newly Emerged Diseases via Network-based Inference on a Gene-disease-drug Network.
    Qin L; Wang J; Wu Z; Li W; Liu G; Tang Y
    Mol Inform; 2022 Sep; 41(9):e2200001. PubMed ID: 35338586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases.
    Fiscon G; Conte F; Farina L; Paci P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug repositioning by integrating target information through a heterogeneous network model.
    Wang W; Yang S; Zhang X; Li J
    Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge-driven drug repurposing using a comprehensive drug knowledge graph.
    Zhu Y; Che C; Jin B; Zhang N; Su C; Wang F
    Health Informatics J; 2020 Dec; 26(4):2737-2750. PubMed ID: 32674665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Drug-Target Network-Based Supervised Machine Learning Repurposing Method Allowing the Use of Multiple Heterogeneous Information Sources.
    Nascimento ACA; Prudêncio RBC; Costa IG
    Methods Mol Biol; 2019; 1903():281-289. PubMed ID: 30547449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.